280 related articles for article (PubMed ID: 35882865)
1. A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors.
Stefan SM; Jansson PJ; Pahnke J; Namasivayam V
Sci Data; 2022 Jul; 9(1):446. PubMed ID: 35882865
[TBL] [Abstract][Full Text] [Related]
2. Structural feature-driven pattern analysis for multitarget modulator landscapes.
Namasivayam V; Stefan K; Silbermann K; Pahnke J; Wiese M; Stefan SM
Bioinformatics; 2022 Feb; 38(5):1385-1392. PubMed ID: 34888617
[TBL] [Abstract][Full Text] [Related]
3. Physicochemistry shapes bioactivity landscape of pan-ABC transporter modulators: Anchor point for innovative Alzheimer's disease therapeutics.
Namasivayam V; Stefan K; Gorecki L; Korabecny J; Soukup O; Jansson PJ; Pahnke J; Stefan SM
Int J Biol Macromol; 2022 Sep; 217():775-791. PubMed ID: 35839956
[TBL] [Abstract][Full Text] [Related]
4. Scaffold fragmentation and substructure hopping reveal potential, robustness, and limits of computer-aided pattern analysis (C@PA).
Namasivayam V; Silbermann K; Pahnke J; Wiese M; Stefan SM
Comput Struct Biotechnol J; 2021; 19():3269-3283. PubMed ID: 34141145
[TBL] [Abstract][Full Text] [Related]
5. C@PA: Computer-Aided Pattern Analysis to Predict Multitarget ABC Transporter Inhibitors.
Namasivayam V; Silbermann K; Wiese M; Pahnke J; Stefan SM
J Med Chem; 2021 Mar; 64(6):3350-3366. PubMed ID: 33724808
[TBL] [Abstract][Full Text] [Related]
6. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.
Schinkel AH; Jonker JW
Adv Drug Deliv Rev; 2003 Jan; 55(1):3-29. PubMed ID: 12535572
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs.
Matsson P; Pedersen JM; Norinder U; Bergström CA; Artursson P
Pharm Res; 2009 Aug; 26(8):1816-31. PubMed ID: 19421845
[TBL] [Abstract][Full Text] [Related]
8. Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics.
Namasivayam V; Stefan K; Pahnke J; Stefan SM
Comput Struct Biotechnol J; 2021; 19():6490-6504. PubMed ID: 34976306
[TBL] [Abstract][Full Text] [Related]
9. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Pedersen JM; Matsson P; Bergström CA; Norinder U; Hoogstraate J; Artursson P
J Med Chem; 2008 Jun; 51(11):3275-87. PubMed ID: 18457386
[TBL] [Abstract][Full Text] [Related]
10. Investigational ABC transporter inhibitors.
Falasca M; Linton KJ
Expert Opin Investig Drugs; 2012 May; 21(5):657-66. PubMed ID: 22493979
[TBL] [Abstract][Full Text] [Related]
11. Availability and applications of ATP-binding cassette (ABC) transporter blockers.
Ponte-Sucre A
Appl Microbiol Biotechnol; 2007 Aug; 76(2):279-86. PubMed ID: 17522856
[TBL] [Abstract][Full Text] [Related]
12. PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo.
Mairinger S; Erker T; Muller M; Langer O
Curr Drug Metab; 2011 Oct; 12(8):774-92. PubMed ID: 21434859
[TBL] [Abstract][Full Text] [Related]
13. Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP.
Kowalski P; Surowiak P; Lage H
Mol Ther; 2005 Apr; 11(4):508-22. PubMed ID: 15771954
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of ABC transporter interaction: potential utility in pharmacology.
Robey RW; Lin B; Qiu J; Chan LL; Bates SE
J Pharmacol Toxicol Methods; 2011; 63(3):217-22. PubMed ID: 21112407
[TBL] [Abstract][Full Text] [Related]
15. Computer-Aided Recognition of ABC Transporters Substrates and Its Application to the Development of New Drugs for Refractory Epilepsy.
Couyoupetrou M; Gantner ME; Di Ianni ME; Palestro PH; Enrique AV; Gavernet L; Ruiz ME; Pesce G; Bruno-Blanch LE; Talevi A
Mini Rev Med Chem; 2017; 17(3):205-215. PubMed ID: 27739362
[TBL] [Abstract][Full Text] [Related]
16. In silico prediction of substrate properties for ABC-multidrug transporters.
Demel MA; Schwaha R; Krämer O; Ettmayer P; Haaksma EE; Ecker GF
Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1167-80. PubMed ID: 18721111
[TBL] [Abstract][Full Text] [Related]
17. The role of ABC transporters in drug resistance, metabolism and toxicity.
Glavinas H; Krajcsi P; Cserepes J; Sarkadi B
Curr Drug Deliv; 2004 Jan; 1(1):27-42. PubMed ID: 16305368
[TBL] [Abstract][Full Text] [Related]
18. Intriguing possibilities and beneficial aspects of transporter-conscious drug design.
Tashima T
Bioorg Med Chem; 2015 Aug; 23(15):4119-4131. PubMed ID: 26138194
[TBL] [Abstract][Full Text] [Related]
19. In vitro methods in drug transporter interaction assessment.
Jani M; Krajcsi P
Drug Discov Today Technol; 2014 Jun; 12():e105-12. PubMed ID: 25027368
[TBL] [Abstract][Full Text] [Related]
20. Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration.
Chaves C; Shawahna R; Jacob A; Scherrmann JM; Declèves X
Curr Pharm Des; 2014; 20(10):1450-62. PubMed ID: 23789951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
